Fujifilm Diosynth Biotechnologies - pAVEway™: A Novel Platform for the Advanced Production of Protein Therapeutics
The pAVEway™ platform developed by Fujifilm Diosynth Biotechnologies is based on a set of unique protein expression plasmids.
-
The pAVEway™ platform developed by Fujifilm Diosynth Biotechnologies is... -
Fujifilm Diosynth Biotechnologies has over 180 process development scientists... -
A pre-cGMP pilot-scale fermenter ensures that processes can be rapidly... -
A full range of manufacturing support services is offered, including... -
On-site cGMP cell banking facilities for the production of master and working...
Twitter
Facebook